Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

1(9%)

Results Posted

25%(2 trials)

Phase Distribution

Ph not_applicable

Ph phase_1

Ph early_phase_1

27%

Ph phase_4

36%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Early Phase 1First-in-human

3(33.3%)

Phase 1Safety & dosage

1(11.1%)

Phase 4Post-market surveillance

4(44.4%)

N/ANon-phased studies

1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(8)

Terminated(1)

Other(1)

Detailed Status

Completed8

Recruiting1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 13 (33.3%)

Phase 11 (11.1%)

Phase 44 (44.4%)

N/A1 (11.1%)

Trials by Status

recruiting19%

completed873%

unknown19%

withdrawn19%

Recent Activity

1 active trials

Showing 5 of 11

recruitingearly_phase_1

Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers

NCT03255941

completedearly_phase_1

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

NCT03197961

View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials

NCT05760144Early Phase 1

Endometrial Biopsy in Progestin Contraceptive Users

Recruiting

NCT03464266Phase 4

The Kampala Women's Bone Study

Completed

NCT03916328Phase 4

BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study

Unknown

NCT03255941Early Phase 1

Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers

Completed

NCT03197961Early Phase 1

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

Completed

NCT02038335

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

Completed

NCT02550067Not Applicable

The Evidence for Contraceptive Options and HIV Outcomes Trial

Completed

NCT01299116Phase 4

Long-Acting Reversible Contraception

Completed

NCT01356927

Same-day Long-acting Reversible Contraception for Medication Abortion

Completed

NCT02534688Phase 4

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Completed

NCT01231451Phase 1

Depot Contraception With and Without Lopinavir/Ritonavir

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 11